GLP-1 receptor agonists derived from Gila monster venom produce multiple physiological effects beyond glucose regulation, including substantial weight reduction, cardiovascular protective benefits, and decreased substance use behaviors.

Study: Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.

The study tested a diabetes drug made from Gila monster venom and found it helps protect the heart, which supports part of the claim. It didn’t test weight loss or effects on substance use, but the heart benefits are real.

Study: Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

The study looked at a diabetes drug made from Gila monster venom and found it may help protect the heart, which supports part of the claim. But it didn’t test whether it helps with weight loss or reducing substance use, so we can’t say if those parts are true based on this study.

Study: GLP-1 receptor agonists are associated with higher mitochondrial coupling efficiency in the human heart

The study shows that diabetes drugs called GLP-1 receptor agonists help the heart's energy factories work more efficiently, which supports their heart-protecting effects. But it doesn't look at weight loss or effects on substance use.

Study: Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

The study looked at diabetes drugs made from Gila monster venom and found they can help people lose weight and reduce alcohol and nicotine use, which supports the idea that these drugs do more than just control blood sugar.